EYLEA (Aflibercept) is a vascular endothelial growth factor (VEGF) inhibitor developed by Regeneron Pharmaceuticals and Bayer for the treatment of various retinal diseases. https://www.coherentmi.com/blog/global-eylea-drug-a-breakthrough-in-treatment-of-retinal-diseases-57